Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B.
Aliment Pharmacol Ther
; 44(10): 1071-1079, 2016 11.
Article
in En
| MEDLINE
| ID: mdl-27659292
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Body Mass Index
/
Hepatitis B, Chronic
/
Liver Cirrhosis
/
Nucleosides
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2016
Document type:
Article
Affiliation country:
Hong Kong
Country of publication:
Reino Unido